Disposable Technologies conference provides forum for pharmaceutical and biopharmaceutical executives to discuss the latest trends in disposable technologies and review critical FDA compliance issues
The event director for this conference, Ellen Dipaolo, announces that Nicholas Buhay, deputy director, FDA/CDER/OC/division of manufacturing and product quality, will be presenting an important discussion on the regulatory considerations of disposable technologies.
In addition to the presentation by Buhay, other companies presenting and in attendance include Bristol Myers Squibb, Pall, Merck, Innogenetics, Amgen, Human Genome Sciences, and Toxikon.
Minimising the risks of cross contamination, maximising an organisation's ROI while cutting costs through the implementation of disposable technologies, and reducing the burden of validation and cleaning steps are among the topics to be discussed at this dynamic event.
Developing and improving relationships with disposable industry vendors will also be a topic of discussion.
A critical focus of this conference will be benefiting from disposable technologies while avoiding 483s and warning letters through case studies addressing cGMP compliance issues.
Case studies and interactive exercises will touch on all of these points.
Among some of the specific sessions to be included in the conference are Implementation of disposables - a validation perspective, Current trends in disposables usage, Implementation of single-use technologies, and more.
IVT's Disposable Technologies for Biopharmaceutical Manufacturing will take place at the Radisson Old Town Alexandria in Alexandria, USA, 27 February - 1 March 2007.
